Literature DB >> 20658195

Prescription of benzodiazepines in Slovenian family medicine: a qualitative study.

Maja Subelj1, Gaj Vidmar, Vesna Svab.   

Abstract

INTRODUCTION: Previous quantitative research showed large variations in prescribing volume and prescribing patterns of benzodiazepines among Slovenian family physicians. We performed a qualitative interview study to investigate how high-prescribing family physicians explain their own prescription.
METHODS: Five family physicians with benzodiazepine prescriptions in volumes larger than 4000 defined daily doses per month and five who prescribed volumes smaller than 2000 defined daily doses per month, selected randomly from the representative sample of Slovenian family physicians, were interviewed. Physicians' self-explanations about their daily decisions regarding benzodiazepine prescribing, patients' and practice characteristics and their attitudes towards patients were analysed.
RESULTS: Family physicians were reporting about patients' needs and their demands, co-morbidity of older patients, previous good experience with benzodiazepines, concerns about decreasing dosage or discontinuation of benzodiazepines, high workload and time constraints, limited access to mental health workers and insufficient education and training.
CONCLUSION: Family physicians consider the task of initiating, withdrawing or reducing benzodiazepines as demanding due to complexity of psychosocial problems, co-morbidity, workload, time-consumingness, need to master counselling skills, demands of their patients, particularly the long-term ones and due to low access to mental health services. The majority of family physicians agreed with restrictions in their prescription based on the guidelines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658195     DOI: 10.1007/s00508-010-1413-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  22 in total

1.  Collaboration between primary care and psychiatric services: does it help family physicians?

Authors:  Stephen Kisely; Debbie Duerden; Susan Shaddick; Ajantha Jayabarathan
Journal:  Can Fam Physician       Date:  2006-07       Impact factor: 3.275

2.  Mental health services in Slovenia.

Authors:  Vesna Svab; Martina Tomori
Journal:  Int J Soc Psychiatry       Date:  2002-09

3.  General practitioners' prescribing patterns of benzodiazepine hypnotics: are elderly patients at particular risk for overprescribing? A report from the Møre & Romsdal Prescription Study.

Authors:  J Straand; K Rokstad
Journal:  Scand J Prim Health Care       Date:  1997-03       Impact factor: 2.581

4.  Variation in prescribing of hypnotics, anxiolytics and antidepressants between 61 general practices.

Authors:  P D Pharoah; D Melzer
Journal:  Br J Gen Pract       Date:  1995-11       Impact factor: 5.386

5.  Frequent attenders in general practice: quality of life, patient satisfaction, use of medical services and GP characteristics.

Authors:  J Kersnik; I Svab; M Vegnuti
Journal:  Scand J Prim Health Care       Date:  2001-09       Impact factor: 2.581

6.  Determinants of customer satisfaction with the health care system, with the possibility to choose a personal physician and with a family doctor in a transition country.

Authors:  J Kersnik
Journal:  Health Policy       Date:  2001-08       Impact factor: 2.980

7.  Why are some doctors high-prescribers of benzodiazepines and minor opiates? A qualitative study of GPs in Norway.

Authors:  T B Dybwad; L Kjølsrød; J Eskerud; E Laerum
Journal:  Fam Pract       Date:  1997-10       Impact factor: 2.267

8.  Alcohol consumption among junior high school students in the community of Litija, Slovenia.

Authors:  M Kolsek
Journal:  J Stud Alcohol       Date:  1994-01

9.  Perceived difficulties in managing ethical problems in family practice in Slovenia: cross-sectional study.

Authors:  Zalika Klemenc-Ketis; Janko Kersnik; Janja Ojstersek
Journal:  Croat Med J       Date:  2008-12       Impact factor: 1.351

10.  The lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectives.

Authors:  Sibyl Anthierens; Hilde Habraken; Mirko Petrovic; Thierry Christiaens
Journal:  Scand J Prim Health Care       Date:  2007-12       Impact factor: 2.581

View more
  6 in total

1.  Patients' and clinicians' experiences and perceptions of the primary care management of insomnia: qualitative study.

Authors:  Zowie Davy; Jo Middlemass; Aloysius N Siriwardena
Journal:  Health Expect       Date:  2013-08-19       Impact factor: 3.377

2.  Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.

Authors:  Carina Lundby; Trine Graabaek; Jesper Ryg; Jens Søndergaard; Anton Pottegård; Dorthe Susanne Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-02-27       Impact factor: 4.335

Review 3.  General practitioners' experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis.

Authors:  Coral Sirdifield; Sibyl Anthierens; Hanne Creupelandt; Susan Y Chipchase; Thierry Christiaens; Aloysius Niroshan Siriwardena
Journal:  BMC Fam Pract       Date:  2013-12-13       Impact factor: 2.497

4.  Benzodiazepine usage and patient preference for alternative therapies: A descriptive study.

Authors:  Fatema-Tun-Naher Sake; Keith Wong; Delwyn J Bartlett; Bandana Saini
Journal:  Health Sci Rep       Date:  2019-02-21

Review 5.  The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients-A Systematic Review.

Authors:  Anja Fog Rasmussen; Sarah Sonne Poulsen; Lykke Ida Kaas Oldenburg; Charlotte Vermehren
Journal:  Metabolites       Date:  2021-04-20

Review 6.  Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis.

Authors:  Kristen Anderson; Danielle Stowasser; Christopher Freeman; Ian Scott
Journal:  BMJ Open       Date:  2014-12-08       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.